Voyager Therapeutics (FRA:VT6) Accumulated other comprehensive income (loss) : €-0.18 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Voyager Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Voyager Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was €-0.18 Mil.

Voyager Therapeutics's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2024 (€-0.03 Mil) to Dec. 2024 (€-0.39 Mil) but then increased from Dec. 2024 (€-0.39 Mil) to Mar. 2025 (€-0.18 Mil).

Voyager Therapeutics's annual Accumulated other comprehensive income (loss) increased from Dec. 2022 (€-0.21 Mil) to Dec. 2023 (€-0.04 Mil) but then declined from Dec. 2023 (€-0.04 Mil) to Dec. 2024 (€-0.39 Mil).

Voyager Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Voyager Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyager Therapeutics Accumulated other comprehensive income (loss) Chart

Voyager Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-0.11

-0.12

-0.21

-0.04

-0.39

Voyager Therapeutics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-0.47	-0.49	-0.03	-0.39	-0.18

Voyager Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Voyager Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Voyager Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyager Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Voyager Therapeutics Inc (FRA:VT6) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

VYGR:USA VYGR:Mexico

Address

75 Hayden Avenue, Lexington, MA, USA, 02421

Website

https://www.voyagertherapeutics.com

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Voyager Therapeutics Headlines

No Headlines